Avraham Ben-Tzvi
Known title: DirectorCIK: 0001944721
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Indaptus named among top small-cap healthcare performers. Indaptus Therapeutics was highlighted in a recent report as one of five smaller health care stocks that outperformed Moderna in September. The stock is currently trading near the upper end of its 52-week range, reflecting this recent strength. This inclusion in a performance-based list draws attention to the company's recent market activity relative to larger peers.
Transaction History
| QUCY | ▲ Buy | Grant | 112,259 | $0 | 7/31/2026 | View on chart |
| QUCY | ▲ Buy | Grant | 137,141 | $0 | 5/8/2026 | View on chart |
| INDP | ▲ Buy | Grant | 25,000 | $0 | 1/20/2026 | View on chart |
| FIEE | ▲ Buy | Grant | 159,364 | — | 9/26/2024 | View on chart |
| FIEE | ▲ Buy | Grant | 25,000 | — | 1/22/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Quantum Cyber Reports Audited Financials and Refines Strategic Focus
Quantum Cyber has released audited and reviewed financial statements for its Bridgeport Manufacturing acquisition. In a new investor presentation, the firm highlighted a sharpened focus on quantum navigation, interceptor drones, and U.S. manufacturing. These updates outline the company’s progress on the acquisition and its strategic priorities moving forward.
Quantum Cyber Reports Audited Financials and Refines Strategic Focus. Quantum Cyber has released audited and reviewed financial statements for its Bridgeport Manufacturing acquisition. In a new investor presentation, the firm highlighted a sharpened focus on quantum navigation, interceptor drones, and U.S. manufacturing. These updates outline the company’s progress on the acquisition and its strategic priorities moving forward.